NCT00304291View on ClinicalTrials.gov

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

May 31, 2004

Conditions
Neuromyelitis OpticaMyelitis, TransverseDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous System
Interventions
DRUG

Mitoxantrone

Trial Locations (1)

14203

Baird Multiple Sclerosis Center, Buffalo

Sponsors

Collaborators (1)

EMD Serono
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

State University of New York at Buffalo

OTHER

NCT00304291 - A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) | Biotech Hunter | Biotech Hunter